Cabane P, Correa C, Bode I, Aguilar R, Elorza A
Int J Mol Sci. 2024; 25(12).
PMID: 38928426
PMC: 11204084.
DOI: 10.3390/ijms25126719.
Luo W, Lu J, Zheng X, Wang J, Qian S, Bai Z
Sci Rep. 2023; 13(1):18454.
PMID: 37891201
PMC: 10611723.
DOI: 10.1038/s41598-023-45287-w.
Chen W, Xie R, Zhang S, Zhou T, Xiong C, Huang D
Am J Transl Res. 2023; 15(8):5110-5119.
PMID: 37692964
PMC: 10492077.
Gulwani D, Upadhyay P, Goel R, Sarangthem V, Singh T
Asian Pac J Cancer Prev. 2023; 24(2):375-387.
PMID: 36853284
PMC: 10162641.
DOI: 10.31557/APJCP.2023.24.2.375.
Soffritti I, DAccolti M, Maccari C, Bini F, Mazziga E, Arcangeletti M
Microorganisms. 2023; 11(2).
PMID: 36838377
PMC: 9958881.
DOI: 10.3390/microorganisms11020412.
LncRNA as a prognostic biomarker for various cancers: A meta-analysis and bioinformatics analysis.
Wang Y, Jiang X, Zhang D, Zhao Y, Han X, Zhu L
Front Genet. 2022; 13:907774.
PMID: 36046244
PMC: 9420988.
DOI: 10.3389/fgene.2022.907774.
MicroRNAs as the critical regulators of cell migration and invasion in thyroid cancer.
Hamidi A, Taghehchian N, Basirat Z, Zangouei A, Moghbeli M
Biomark Res. 2022; 10(1):40.
PMID: 35659780
PMC: 9167543.
DOI: 10.1186/s40364-022-00382-4.
SLC8A1 antisense RNA 1 suppresses papillary thyroid cancer malignant progression via the FUS RNA binding protein (FUS)/NUMB like endocytic adaptor protein (Numbl) axis.
Xin Y, Shang X, Sun X, Xu G, Liu Y, Liu Y
Bioengineered. 2022; 13(5):12572-12582.
PMID: 35599603
PMC: 9275960.
DOI: 10.1080/21655979.2022.2073125.
MEK1/2 inhibitor inhibits neointima formation by activating miR-126-3p/ C-X-C motif chemokine ligand 12 (CXCL12)/C-X-C motif chemokine receptor 4 (CXCR4) axis.
Yan Y, Zhu M, Ma J, He X, Yang X, Xu H
Bioengineered. 2022; 13(4):11214-11227.
PMID: 35485167
PMC: 9208476.
DOI: 10.1080/21655979.2022.2063496.
The double homeobox a pseudogene 8 accelerates cell proliferation, migration, and invasion in colon cancer.
Mao S, Mo Z, Wu R, Lai B, Zhou Z, Song Y
Bioengineered. 2022; 13(4):8164-8173.
PMID: 35287542
PMC: 9161926.
DOI: 10.1080/21655979.2022.2053802.
Long non-coding RNA CATIP antisense RNA 1 (lncRNA CATIP-AS1) downregulation contributes to the progression and metastasis of thyroid cancer via epithelial-mesenchymal transition (EMT) pathway.
Qi F, Tang J, Cai Z, Wang G, Wang Z
Bioengineered. 2022; 13(3):7592-7606.
PMID: 35264071
PMC: 8973971.
DOI: 10.1080/21655979.2022.2047400.
Hsa_circ_0048674 facilitates hepatocellular carcinoma progression and natural killer cell exhaustion depending on the regulation of miR-223-3p/PDL1.
Li S, Chen Z, Zhou R, Wang S, Wang W, Liu D
Histol Histopathol. 2022; 37(12):1185-1199.
PMID: 35187630
DOI: 10.14670/HH-18-440.
Functions of lncRNA DUXAP8 in non-small cell lung cancer.
Wu C, Song W, Wang Z, Wang B
Mol Biol Rep. 2022; 49(3):2531-2542.
PMID: 35031926
DOI: 10.1007/s11033-021-07066-6.
Circular RNA protein tyrosine kinase 2 (circPTK2) promotes colorectal cancer proliferation, migration, invasion and chemoresistance.
Jiang Z, Hou Z, Liu W, Yu Z, Liang Z, Chen S
Bioengineered. 2022; 13(1):810-823.
PMID: 34974791
PMC: 8805883.
DOI: 10.1080/21655979.2021.2012952.
YY1-induced long non-coding RNA PSMA3 antisense RNA 1 functions as a competing endogenous RNA for microRNA 214-5p to expedite the viability and restrict the apoptosis of bladder cancer cells via regulating programmed cell death-ligand 1.
Zhang M, Xu Y, Yin S, Qiu F
Bioengineered. 2021; 12(2):9150-9161.
PMID: 34720049
PMC: 8809964.
DOI: 10.1080/21655979.2021.1994907.
Long non-coding RNA SNHG22 facilitates hepatocellular carcinoma tumorigenesis and angiogenesis via DNA methylation of microRNA miR-16-5p.
Zhang Y, Lu C, Cui H
Bioengineered. 2021; 12(1):7446-7458.
PMID: 34652260
PMC: 8806779.
DOI: 10.1080/21655979.2021.1975969.
Identification of potential targets of triptolide in regulating the tumor microenvironment of stomach adenocarcinoma patients using bioinformatics.
Qiu H, Zhang X, Yu H, Gao R, Shi J, Shen T
Bioengineered. 2021; 12(1):4304-4319.
PMID: 34348580
PMC: 8806726.
DOI: 10.1080/21655979.2021.1945522.
ETS like-1 protein ELK1-induced lncRNA LINC01638 accelerates the progression of papillary thyroid cancer by regulating Axin2 through Wnt/β-catenin signaling pathway.
Lv P, Xue Y
Bioengineered. 2021; 12(1):3873-3885.
PMID: 34281460
PMC: 8806727.
DOI: 10.1080/21655979.2021.1935404.
Silencing of the chemokine CXC receptor 4 (CXCR4) hampers cancer progression and increases cisplatin (DDP)-sensitivity in clear cell renal cell carcinoma (ccRCC).
Wang W, Gan Z, Liu Q, Yan S, Mulati R, Wang Y
Bioengineered. 2021; 12(1):2957-2969.
PMID: 34180759
PMC: 8806489.
DOI: 10.1080/21655979.2021.1943112.
MicroRNA-17-5p inhibits thyroid cancer progression by suppressing Early growth response 2 (EGR2).
Geng X, Sun Y, Fu J, Cao L, Li Y
Bioengineered. 2021; 12(1):2713-2722.
PMID: 34130587
PMC: 8806695.
DOI: 10.1080/21655979.2021.1935137.